Cancer biomarker discovery
Sengenics KREX® technology measures antibody biomarkers with industry-leading precision
Disease detection | Tailored treatments | Outcome prediction | Disease subtyping | Patient stratification
Discover why antibody biomarkers hold the potential to transform patient care in our comprehensive white paper. Download the white paper to explore how we can redefine precision medicine:
Early Diagnosis: Understand the power of antibody biomarkers in identifying chronic diseases at their onset.
Treatment Tailoring: Learn how these biomarkers can predict individual treatment responses and mitigate the risk of adverse effects.
Technological Edge: Delve into the precision of Sengenics’ patented KREX® technology for accurate antibody screening.
Impacts on Research: See how antibody biomarkers are not just predictive tools but also key to unlocking disease pathways, essential for novel drug development.
"*" indicates required fields
Sengenics KREX® technology measures antibody biomarkers with industry-leading precision
Disease detection | Tailored treatments | Outcome prediction | Disease subtyping | Patient stratification
Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.
© 2024 Sengenics Corporation LLC. All rights reserved. Sengenics Corporation LLC. Registered in Delaware, USA no. 5739583 | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D
Terms & Conditions | Terms of Use | Privacy Statement | Cookie Policy | Code of Conduct | Whistleblowing Policy | Sitemap
Design and development by RainCastle Communications.
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields
"*" indicates required fields